alpha-Interferon down-regulates epidermal growth factor receptors on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon

Cancer Res. 1991 Nov 1;51(21):5881-7.

Abstract

The CaKi-I line of renal carcinoma (RC) cells is highly sensitive to the antiproliferative effect of human leukocyte interferon (IFN-alpha). These RC cells express high numbers of cell surface receptors for epidermal growth factor (EGF), and EGF stimulates their proliferation. IFN-alpha blocks EGF-stimulated proliferation of these cells and down-regulates EGF receptors (EGFR) by inhibiting EGFR synthesis. Although EGF stimulates the proliferation of RC cells resistant to the antiproliferative action of IFN-alpha, IFN-alpha treatment does not block the EGF-stimulated proliferation of these cells and has no effect on EGFR expression. Thus, the down-regulation of EGFR is specific for RC cells sensitive to IFN-alpha. While IFN-alpha does not affect the level of total cellular message or total polyadenylated message for the EGFR, IFN-alpha treatment decreases the level of cytoplasmic EGFR message. Analysis of polysome distribution of cellular mRNAs indicates that IFN-alpha treatment results in an accumulation of EGFR mRNA in lighter polysome fractions, consistent with a partial block in translational elongation. Thus, IFN-alpha regulates the expression of EGFR and possibly other growth-related proteins by post-transcriptional mechanisms, which may play an important part in the complex inhibitory action of IFN-alpha on RC proliferation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Carcinoma, Renal Cell
  • Cell Division / drug effects*
  • Cell Line
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Epidermal Growth Factor / metabolism
  • Epidermal Growth Factor / pharmacology*
  • ErbB Receptors / biosynthesis*
  • ErbB Receptors / drug effects
  • ErbB Receptors / genetics
  • Gene Expression / drug effects
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics
  • Humans
  • Interferon Type I / pharmacology*
  • Kidney Neoplasms
  • Kinetics
  • Poly A / genetics
  • Polyribosomes / drug effects
  • Polyribosomes / metabolism
  • RNA / drug effects
  • RNA / genetics
  • RNA, Messenger
  • Recombinant Proteins

Substances

  • Interferon Type I
  • RNA, Messenger
  • Recombinant Proteins
  • Poly A
  • Epidermal Growth Factor
  • RNA
  • Glyceraldehyde-3-Phosphate Dehydrogenases
  • ErbB Receptors